These results demonstrate that SETD2 deletion increases the lipid accumulation and the incidence of ccRCC in PKD mice, highlighting the metabolic regulatory function of SETD2 in the transition from PDK to ccRCC. Here, SETD2 is linked to nonpapillary renal cell carcinoma.